Literature DB >> 16168185

Increased serum formate in the diagnosis of methanol poisoning.

Knut E Hovda1, Petter Urdal, Dag Jacobsen.   

Abstract

Early diagnosis is essential for successful treatment in methanol poisoning. Methanol detection by gas chromatography is not available in most hospitals. Methanol increases the osmolal gap in serum and its metabolite formate increases the anion gap. The sensitivity of these indirect diagnostic methods is not good at low concentrations of methanol or formate. We therefore studied the usefulness of formate measurement in diagnosing methanol poisoning. In 15 patients poisoned with methanol, serum formate was measured enzymatically on a Cobas Mira analyzer using formate dehydrogenase and nicotinamid adenine dinucleotid. Day-to-day coefficient of variation was 5%, and the upper reference limit was 2 mg/dL (0.4 mmol/L). Methanol was detected in all 15 patients of whom 14 had elevated serum formate concentrations. Anion gap was increased in 11 of 11, and osmolal gap in 11 patients of 15 examined. Metabolic acidosis was present in 12 of 15 patients, but pH was below 7.30 in only 9 of them. Four patients with no symptoms had formate concentrations in the range 2-38 mg/dL (0.5-8.3 mmol/L), indicating that increased serum formate was a sensitive indicator of methanol poisoning. Our results proved formate analyzes to be a simple, sensitive, and specific way of diagnosing methanol poisoning. Confounders are patients admitted early, or concomitant ethanol ingestion, and therefore no acidosis. This problem may, however, be omitted by repeated formate analysis in patients developing metabolic acidosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16168185     DOI: 10.1093/jat/29.6.586

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  7 in total

Review 1.  Antidotes for poisoning by alcohols that form toxic metabolites.

Authors:  Kenneth McMartin; Dag Jacobsen; Knut Erik Hovda
Journal:  Br J Clin Pharmacol       Date:  2016-01-04       Impact factor: 4.335

2.  Positive serum ethanol concentration on admission to hospital as the factor predictive of treatment outcome in acute methanol poisoning.

Authors:  Sergey Zakharov; Olga Nurieva; Katerina Kotikova; Jaromir Belacek; Tomas Navratil; Daniela Pelclova
Journal:  Monatsh Chem       Date:  2016-10-25       Impact factor: 1.451

3.  Probing the Role of the Conserved Arg174 in Formate Dehydrogenase by Chemical Modification and Site-Directed Mutagenesis.

Authors:  Mohammed Hamed Alqarni; Ahmed Ibrahim Foudah; Magdy Mohamed Muharram; Haritium Budurian; Nikolaos E Labrou
Journal:  Molecules       Date:  2021-02-25       Impact factor: 4.411

Review 4.  Methanol poisoning as a new world challenge: A review.

Authors:  Zahra Nekoukar; Zakaria Zakariaei; Fatemeh Taghizadeh; Fatemeh Musavi; Elham Sadat Banimostafavi; Ali Sharifpour; Nasrin Ebrahim Ghuchi; Mahdi Fakhar; Rabeeh Tabaripour; Sepideh Safanavaei
Journal:  Ann Med Surg (Lond)       Date:  2021-06-02

5.  Intermittent hemodialysis is superior to continuous veno-venous hemodialysis/hemodiafiltration to eliminate methanol and formate during treatment for methanol poisoning.

Authors:  Sergey Zakharov; Daniela Pelclova; Tomas Navratil; Jaromir Belacek; Ivana Kurcova; Ondrej Komzak; Tomas Salek; Jiri Latta; Radovan Turek; Robert Bocek; Cyril Kucera; Jaroslav A Hubacek; Zdenka Fenclova; Vit Petrik; Martin Cermak; Knut Erik Hovda
Journal:  Kidney Int       Date:  2014-03-12       Impact factor: 10.612

Review 6.  Treatment of patients with ethylene glycol or methanol poisoning: focus on fomepizole.

Authors:  Bruno Mégarbane
Journal:  Open Access Emerg Med       Date:  2010-08-24

7.  The Methanol Poisoning Outbreaks in Libya 2013 and Kenya 2014.

Authors:  Morten Rostrup; Jeffrey K Edwards; Mohamed Abukalish; Masoud Ezzabi; David Some; Helga Ritter; Tom Menge; Ahmed Abdelrahman; Rebecca Rootwelt; Bart Janssens; Kyrre Lind; Raido Paasma; Knut Erik Hovda
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.